Hartl J - Search Results

1

Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.

Hartl J, Ehlken H, Sebode M, Peiseler M, Krech T, Zenouzi R, von Felden J, Weiler-Normann C, Schramm C, Lohse AW. Hartl J, et al. J Hepatol. 2018 Apr;68(4):754-763. doi: 10.1016/j.jhep.2017.11.020. Epub 2017 Nov 24. J Hepatol. 2018. PMID: 29180000

2

An unresectable Klatskin's tumor?

Hartl J, Werner T, Schramm C. Hartl J, et al. Gastroenterology. 2014 Jun;146(7):e3-4. doi: 10.1053/j.gastro.2014.01.011. Epub 2014 Apr 26. Gastroenterology. 2014. PMID: 24780210 No abstract available.

3

[Autoimmune hepatitis: news about a disease on the rise].

Zenouzi R, Hartl J, Lohse AW. Zenouzi R, et al. Among authors: hartl j. Dtsch Med Wochenschr. 2014 Oct;139(40):2020-2. doi: 10.1055/s-0034-1370288. Epub 2014 Oct 17. Dtsch Med Wochenschr. 2014. PMID: 25325379 Review. German. No abstract available.

4

Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis.

Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, Zenouzi R, Glaubke C, Lohse AW, Schramm C. Hartl J, et al. J Hepatol. 2015 Mar;62(3):642-6. doi: 10.1016/j.jhep.2014.10.018. Epub 2014 Oct 18. J Hepatol. 2015. PMID: 25457202

5

Efficacy and safety of sofosbuvir-based triple therapy in hepatitis C genotype 4 infection.

Wehmeyer MH, Jordan S, Lüth S, Hartl J, Stoehr A, Eißing C, Lohse AW, Petersen J, Buggisch P, Schulze Zur Wiesch J. Wehmeyer MH, et al. Among authors: hartl j. Dig Liver Dis. 2015 Sep;47(9):811-4. doi: 10.1016/j.dld.2015.05.018. Epub 2015 May 24. Dig Liver Dis. 2015. PMID: 26091766

6

Comparison of autochthonous and imported cases of hepatitis A or hepatitis E.

Hartl J, Kreuels B, Polywka S, Addo M, Luethgehetmann M, Dandri M, Dammermann W, Sterneck M, Lohse AW, Pischke S. Hartl J, et al. Z Gastroenterol. 2015 Jul;53(7):639-43. doi: 10.1055/s-0034-1399236. Epub 2015 Jul 13. Z Gastroenterol. 2015. PMID: 26167693

7

Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis.

Ehlken H, Wroblewski R, Corpechot C, Arrivé L, Lezius S, Hartl J, Denzer UW, Lohse AW, Chazouilleres O, Schramm C. Ehlken H, et al. Among authors: hartl j. Gut. 2016 Jul;65(7):1230-2. doi: 10.1136/gutjnl-2016-311452. Epub 2016 Feb 26. Gut. 2016. PMID: 26921347 No abstract available.

8

Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis.

Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, Hübener S, Pannicke N, Weiler-Normann C, Quaas A, Lohse AW, Schramm C. Hartl J, et al. J Hepatol. 2016 Oct;65(4):769-775. doi: 10.1016/j.jhep.2016.05.023. Epub 2016 May 26. J Hepatol. 2016. PMID: 27238753

9

Hepatitis E Seroprevalence in Europe: A Meta-Analysis.

Hartl J, Otto B, Madden RG, Webb G, Woolson KL, Kriston L, Vettorazzi E, Lohse AW, Dalton HR, Pischke S. Hartl J, et al. Viruses. 2016 Aug 6;8(8):211. doi: 10.3390/v8080211. Viruses. 2016. PMID: 27509518 Free PMC article. Review.

10

No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.

Zenouzi R, Weismüller TJ, Jørgensen KK, Bubenheim M, Lenzen H, Hübener P, Schulze K, Weiler-Normann C, Sebode M, Ehlken H, Pannicke N, Hartl J, Peiseler M, Hübener S, Karlsen TH, Boberg KM, Manns MP, Lohse AW, Schramm C. Zenouzi R, et al. Among authors: hartl j. Clin Gastroenterol Hepatol. 2016 Dec;14(12):1806-1812. doi: 10.1016/j.cgh.2016.07.032. Epub 2016 Aug 10. Clin Gastroenterol Hepatol. 2016. PMID: 27521513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters